Information Provided By: 
Fly News Breaks for June 20, 2018
BEAT
Jun 20, 2018 | 08:27 EDT
Benchmark analyst Bill Sutherland said his meetings with BioTelemetry management granted additional insight into new product initiatives that are leading to better revenue momentum. Management "readily concedes" its initial full-year guidance is conservative and he thinks it may be adjusted following the Q2 report, Sutherland tells investors. He raised his price target on BioTelemetry shares to $54 from $46 and keeps a Buy rating on the stock.
News For BEAT From the Last 2 Days
There are no results for your query BEAT
